Created in 2010 and published by Impact Journals, Oncotarget is a weekly journal that focuses on the research done for all types on oncology as well as treatments and pathological basis for cancer. It is an international journal provided with peer-review and open access, allowing the opportunity for plenty of further involvement in the study and ambitious hopes to destroy of cancer once and for all. Oncotarget as a united front has many goals, all of which are closely associated with the advancement and maximization of clinical science in the medical industry – and to fill gaps in both the general and advanced knowledge pools – but the ultimate mission is to rid the world of diseases.
With the gradually growing success of Mikhail Blagosklonny as well as reaching new records on the Impact Factor rate, they have decided to branch out to other sections in medical science rather than remaining in oncology only. Topics such as aging, neuroscience, metabolism, to name a few, are now being discussed, researched, and then included in the journal thanks to the efforts of everyone tirelessly working together to maintain the Oncotarget journal’s essential existence.
The editors-in-chief to Oncotarget, Mikhail Blagosklonny and Andrei V. Gudkov, are also on the personnel of the Roswell Park Cancer Institute, which was founded in 1898 and is located in Buffalo, New York. The Roswell Park Cancer Institute is a facility devoted to cancer treatment and research; the length of its continuance speaking volumes towards the confidence and satisfaction directly associated with the highly rated medical care and professionalism.